These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21083241)

  • 1. Novel MS solutions inspired by MIST.
    Ramanathan R; Josephs JL; Jemal M; Arnold M; Humphreys WG
    Bioanalysis; 2010 Jul; 2(7):1291-313. PubMed ID: 21083241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
    Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
    Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An accurate-mass-based spectral-averaging isotope-pattern-filtering algorithm for extraction of drug metabolites possessing a distinct isotope pattern from LC-MS data.
    Zhu P; Tong W; Alton K; Chowdhury S
    Anal Chem; 2009 Jul; 81(14):5910-7. PubMed ID: 19518135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-low flow nanospray for the normalization of conventional liquid chromatography/mass spectrometry through equimolar response: standard-free quantitative estimation of metabolite levels in drug discovery.
    Valaskovic GA; Utley L; Lee MS; Wu JT
    Rapid Commun Mass Spectrom; 2006; 20(7):1087-96. PubMed ID: 16506151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?
    Nassar AE; Talaat RE; Kamel AM
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):61-74. PubMed ID: 16445118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
    Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
    J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput quantitative bioanalysis by LC/MS/MS.
    Jemal M
    Biomed Chromatogr; 2000 Oct; 14(6):422-9. PubMed ID: 11002279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches.
    Liu DQ; Hop CE
    J Pharm Biomed Anal; 2005 Feb; 37(1):1-18. PubMed ID: 15664738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of relative LC/MS response of metabolites to parent drug in LC/nanospray ionization mass spectrometry: potential implications in MIST assessment.
    Schadt S; Chen LZ; Bischoff D
    J Mass Spectrom; 2011 Dec; 46(12):1281-6. PubMed ID: 22223420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR spectroscopy as a tool to close the gap on metabolite characterization under MIST.
    Caceres-Cortes J; Reily MD
    Bioanalysis; 2010 Jul; 2(7):1263-76. PubMed ID: 21083239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies.
    Tiller PR; Yu S; Bateman KP; Castro-Perez J; McIntosh IS; Kuo Y; Baillie TA
    Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3510-6. PubMed ID: 18853407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles and applications of LC-MS in new drug discovery.
    Korfmacher WA
    Drug Discov Today; 2005 Oct; 10(20):1357-67. PubMed ID: 16253874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
    Ermer J; Vogel M
    Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution isotope-dilution mass spectrometry using metabolism of isotope-labeled compounds: application to drug metabolites.
    Vrbanac JJ; Hilgers A; Dubnicka T; Shilliday FB; Humphries D; Hayes RN
    Rapid Commun Mass Spectrom; 2012 Nov; 26(22):2569-76. PubMed ID: 23059872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple liquid-liquid extraction with hexane for low-picogram determination of drugs and their metabolites in plasma by high-performance liquid chromatography with positive ion electrospray tandem mass spectrometry.
    Xia YQ; Whigan DB; Jemal M
    Rapid Commun Mass Spectrom; 1999; 13(15):1611-21. PubMed ID: 10421903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography-mass spectrometry in the study of the metabolism of drugs and other xenobiotics.
    Oliveira EJ; Watson DG
    Biomed Chromatogr; 2000 Oct; 14(6):351-72. PubMed ID: 11002274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdosing: a valuable tool for accelerating drug development and the role of bioanalytical methods in meeting the challenge.
    Ings RM
    Bioanalysis; 2009 Oct; 1(7):1293-305. PubMed ID: 21083052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ternary-column system for high-throughput direct-injection bioanalysis by liquid chromatography/tandem mass spectrometry.
    Xia YQ; Whigan DB; Powell ML; Jemal M
    Rapid Commun Mass Spectrom; 2000; 14(2):105-11. PubMed ID: 10623938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.